BioSig Technologies, Inc. STEX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s common stock, shares authorized (in shares)?
- BioSig Technologies, Inc. (STEX) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
- How has BioSig Technologies, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- BioSig Technologies, Inc.'s common stock, shares authorized (in shares) increased by 150.0% year-over-year, from $200M to $500M.
- What is the long-term trend for BioSig Technologies, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s common stock, shares authorized (in shares) has grown at a 20.1% compound annual growth rate (CAGR), from $200M to $500M.